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Controlling with light the interaction between
trans-tetrapyridyl ruthenium complexes and an
oligonucleotide†
Vincent H. S. van Rixel,a Geri F. Moolenaar,a Maxime A. Siegler, b Luigi Messori c
and Sylvestre Bonnet *a
Three new trans-ruthenium(II) complexes coordinated to tetrapyridyl ligands, namely [Ru(bapbpy)(dmso)
Cl]Cl ([2]Cl), [Ru(bapbpy)(Hmte)2](PF6)2 ([3](PF6)2), and [Ru(biqbpy)(Hmte)2](PF6)2 ([4](PF6)2), were prepared
as analogues of [Ru(biqbpy)(dmso)Cl]Cl ([1]Cl), a recently described photoactivated chemotherapy agent.
The new complexes were characterized, and their crystal structures showed the distorted coordination
octahedron typical of this family of complexes. Their photoreactivity in solution was analyzed by spectro-
photometry and mass spectrometry, which showed that the sulfur ligand was substituted upon blue light
irradiation. The binding of the ruthenium complexes to a reference single-stranded oligonucleotide
(s(5’CTACGGTTTCAC3’)) was explored both in the dark and under light irradiation by gel electrophoresis
and high-resolution mass spectrometry. While adduct formation in the dark was negligible for the four
complexes, light irradiation led to the formation of adducts with one or two ruthenium centers per oligo-
nucleotide. The absence of interactions in the dark and the presence of complex–oligonucleotide
adducts demonstrate that visible light controls the interaction of these ruthenium complexes with nucleic
acids.
Introduction
The leading anti-cancer drug cisplatin is one of the landmarks
in modern inorganic chemistry.1 In the body cisplatin enters
cells, hydrolyzes, and forms irreversible adducts with DNA,
ultimately triggering cell death via apoptosis.2–5 However,
because of its lack of selectivity, severe side-effects are com-
monly associated with the use of cisplatin, including nephro-
toxicity, neurotoxicity, ototoxicity, and nausea.6 Furthermore,
cancer cells can acquire increasing levels of cisplatin-resis-
tance.7 Alternatively, as transplatin is not active in vivo and less
cytotoxic than cisplatin in vitro, anticancer metallodrugs with
a trans geometry have not been seriously considered until
recently.8–12
Photodynamic therapy (PDT) is used in the clinic to locally
activate anticancer pro-drugs, improve their selectivity, and
reduce their side effects. PDT relies on the local activation of
ground state triplet oxygen to highly reactive excited state
singlet oxygen, thus critically depending on the presence of
dioxygen. In anticancer therapy, photo-activated chemotherapy
(PACT) is an emerging alternative strategy based on com-
pounds that are chemically modified upon light irradiation
without depending on the presence of oxygen.13–21 Notably,
platinum-based PACT compounds have been described and
often rely on the photoreduction of an octahedral platinum(IV)
center to a square planar platinum(II) complex.14,22–25
Transplatin is also much more cytotoxic after UVA light
irradiation than in the dark.25 However, light-activated plati-
num complexes often lack strong absorption in the visible
region, which is a problem for photochemotherapy in vivo.
Ruthenium(II) polypyridyl compounds have emerged as a
promising alternative due to their excellent visible-light
absorption properties.26,27 Most of the ruthenium-based PACT
agents known to date contain two bidentate ligands based on
the 2,2-bipyridine scaffold.13,28–31 After light activation, a cis-
bisaqua complex is obtained that can bind to DNA in a fashion
similar to cisplatin.32
By contrast, the trans compound [Ru(biqbpy)(dmso)Cl]Cl
([1]Cl) (biqbpy = 6,6′-bis[N-(isoquinolyl)-1-amino]-2,2′-bipyri-
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dine) has recently been reported as a phototoxic PACT agent
that induces apoptosis upon green light activation.33 This new
type of octahedral ruthenium complex consists of a tetrapyri-
dyl biqbpy ligand that coordinates in the basal plane of the
octahedron, allowing the coordination of two trans axial mono-
dentate ligands that can be photochemically or thermally sub-
stituted. In our initial study we reported that a significant
amount of ruthenium ends up in the nucleus of the cell,
which justified DNA-binding studies using gel electrophoresis
and circular pUC19 DNA plasmid. These studies clearly
showed that the interaction with DNA was switched on by light
irradiation. However, the nature of the metal–DNA adducts
was unclear. In this work, we present three new derivatives of
[1]Cl: [Ru(biqbpy)(Hmte)2](PF6)2 ([2](PF6)2, Hmte = 2-methyl-
thioethanol), and two bapbpy analogues [Ru(bapbpy)
(dmso)Cl]Cl ([3]Cl) and [Ru(bapbpy)(Hmte)2](PF6)2 ([4](PF6)2,
(bapbpy = 6,6′-bis[N-(pyridyl)-1-amino]-2,2′-bipyridine)), and
studied their interaction, in the dark and under light
irradiation, with the oligodeoxyribonucleotide (ODN)
s(5′CTACGGTTTCAC3′) (ODN1). Oligonucleotides have been
widely used as models for DNA, to study its interaction with
potential anti-cancer compounds.34–38 For the first time in
PACT we introduce here a combined gel electrophoresis and
high resolution electrospray injection mass spectrometry




The complex [Ru(bapbpy)(dmso)Cl]Cl ([2]Cl) was synthesized
by reacting bapbpy with 1.1 equivalents of [Ru(dmso)4Cl2] in
ethanol overnight at 80 °C (Scheme 1) following the synthetic
approach to [1]Cl.33 Reacting [1]Cl or [2]Cl with an excess of
Hmte overnight at 80 °C in water, followed by anion exchange
using KPF6, and size-exclusion chromatography, afforded [3]
(PF6)2 and [4](PF6)2, respectively (Scheme 1). In this reaction
the chloride ligand instantly hydrolyzes, but an excess of
thioether and heat were required to also substitute thermally
the dmso ligand. In [3](PF6)2 and [4](PF6)2 an upfield shift of
the 1H NMR signals corresponding to the methyl group of
Hmte was observed (1.53 and 1.56 ppm in acetone-d6, respect-
ively), compared to free Hmte (2.11 ppm). This upfield shift is
characteristic of the shielding cone of polypyridyl ligands co-
ordinated to the metal center, and indicated that Hmte was co-
ordinated to ruthenium.33,39
Crystal structures of the ruthenium compounds
Slow vapor diffusion of ethyl acetate into a methanol solution
containing [2]Cl, and vapor diffusion of diethyl ether into an
acetone solution of [3](PF6)2 or [4](PF6)2 yielded ruby-colored
crystals suitable for X-ray structure determination. In the struc-
ture of [2]Cl, [3](PF6)2 and [4](PF6)2, the dmso or Hmte ligands
were found to bind via their sulfur atom to ruthenium, as
expected from the softness of the sulfur and ruthenium(II)
atoms (Fig. 1). In the structure of [2]Cl, two slightly different
geometries were found in the asymmetric unit. Selected bond
distances, angles, torsion angles, and dihedral angles are sum-
marized in Tables 1 and 2. The bond distances Ru–N1 and
Ru–N6 fall between 2.09 and 2.11 Å, compared to 2.02–2.04 Å
for Ru–N3 and Ru–N4. For [2a]Cl like for [1]Cl (Van Rixel
et al.33) the Ru–S1 bond was 2.2266(13) Å, whereas the Ru–S1
bonds for [3](PF6)2 and [4](PF6)2 were 2.3661(7) and 2.3822(8)
Å, respectively. This difference in bond length can be explained
by the more electron-accepting character of the sulfoxide
ligand and the better π-donating character of the chloride
ligand trans to dmso, compared to Hmte. In [1]Cl and [2]Cl
back-bonding into the dmso π* orbital is increased thereby
resulting in a shorter Ru–S bond length.
The torsion angle N1–N3–N4–N6 in all four complexes
varied between 9.88 and 13.72°. The dihedral angle between
the average planes of the terminal pyridyl or quinolyl moiety of
the ligand, here labelled as the N1 and N6 plane, is also a
measure of the flatness of the tetrapyridyl ligand. For [1]Cl, [2]
Cl, [3](PF6)2 and [4](PF6)2 these angles are 45.38, 30.36 or
42.89, 44.50 and 30.40°, respectively. These values for [2]Cl
and [4](PF6)2 strongly deviate due to the crystal lattice effects
(polar π and hydrogen bonding interactions). Nonetheless, all
the data demonstrate that the ruthenium complexes are dis-
torted, due to the steric hindrance between the two hydrogen
atoms borne by the C1 and C20 or C28 carbon atoms that con-
strains the ligand conformation to wrap in a helical fashion
around the metal center.40,41 Neither the nature of the trans
ligands (Hmte vs. dmso) nor the replacement of the terminal
pyridyl moiety (in bapbpy) by an isoquinolyl moiety (in
biqbpy) has a strong effect on the bond angles and coordi-
nation bond distances of the tetrapyridyl ligand.
Photoreactivity of [2]Cl, [3](PF6)2, and [4](PF6)2
The photoreactivity of [2]Cl, [3](PF6)2, and [4](PF6)2 was tested
under blue light irradiation (λexc = 445 nm) in aqueous solu-
tion and monitored by mass spectrometry and UV-vis spec-
troscopy. For [2]Cl, initially dissolved in CD3OD, mass spec-
trometry before irradiation and for the dark control samples
(Fig. S2A†) showed peaks at m/z = 280.3 corresponding to
[Ru(bapbpy)(dmso)(CD3OD)]
2+ (calc. m/z = 280.1), indicating
Scheme 1 Synthesis of tetrapyridyl ruthenium complexes [1]Cl and [2]
Cl, and their trans Hmte analogues [3](PF6)2 and [4](PF6)2. The conditions
were adapted from Van Rixel et al.33
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that the chloride ligand hydrolyzed quickly and spontaneously
upon dissolution in water, but that dmso was thermally stable.
After light irradiation, however, these peaks were replaced by a
new set of peaks at m/z = 249.7 corresponding to [Ru(bapbpy)
(H2O)(CD3OD)]
2+ (calc. m/z = 250.0) (Fig. S2B†). This indicates
that the dmso ligand in [2]Cl (similar to [1]Cl) is quantitatively
photosubstituted by a solvent molecule. When the photoreac-
tion was followed by UV-vis spectroscopy, irradiation of [2]Cl
was characterized by isosbestic points at 281 and 302 nm, and
resulted, in the steady-state, in a new spectrum characterized
by absorption maxima at 306, 335, 404 and 495 nm, similar to
what was previously reported for [1]Cl (Fig. 2A). The quantum
yield for the photosubstitution of dmso by water was 0.004
and comparable to that found for [1]Cl.33
For [3](PF6)2 and [4](PF6)2 blue light irradiation in aqueous
solution analyzed afterwards by mass spectrometry showed
peaks at m/z = 317.2 and m/z = 266.9 corresponding to [3 –
Hmte]2+ and [4 – Hmte]2+, respectively (calc. m/z = 317.1 and
267.0, see Fig. S3†). The dark control samples also showed
these peaks, but in addition peaks at m/z = 363.0 and m/z =
313.1 corresponding to [3]2+ and [4]2+ (calc. m/z = 363.1 and
313.1, Fig. S4†) were detected. These data indicate that blue
light irradiation of complexes [3](PF6)2 and [4](PF6)2 results in
the photosubstitution of one Hmte ligand for a weakly bound
solvent molecule that is removed in the mass spectrometer.
When the irradiation reaction of [3](PF6)2 was followed by UV-
vis spectroscopy the spectrum evolved over time showing an
overall increase in intensity and a slight red-shift of the metal-
to-ligand-charge transfer (MLCT) from 451 nm to 465 nm
(Fig. 2B). Upon irradiation of a solution of [4](PF6)2, a general
increase in the visible domain through an isosbestic point at
398 nm was observed (Fig. S5†). Overall, the three new com-
plexes show and confirm that the coordination of bapbpy or
Fig. 1 Displacement ellipsoid plots (50% probability level) of the cationic part, as observed in the asymmetric unit of (2 × [2]Cl) (A), ([3](PF6)2) (B),
and ([4](PF6)2) (C) at 110(2) K. Counter anions and H atoms have been omitted for clarity.
Table 1 Selected bond lengths (Å) for [1]Cl, [2a]Cl, [2b]Cl, [3](PF6)2, and
[4](PF6)2. See Fig. 1 for atom numbering
Bond [1]Cla [2a]Cl [2b]Cl [3](PF6)2 [4](PF6)2
Ru–N1 2.1018(19) 2.102(4) 2.098(4) 2.109(3) 2.101(3)
Ru–N3 2.020(2) 2.027(4) 2.023(4) 2.036(2) 2.029(3)
Ru–N4 2.0220(19) 2.031(4) 2.028(4) 2.025(3) 2.029(3)
Ru–N6 2.087(2) 2.098(4) 2.089(4) 2.098(2) 2.101(3)
Ru–Cl 2.4363(5) 2.4513(13) 2.4360(11) — —
Ru–S1 2.2262(6) 2.2266(13) 2.2260(11) 2.3661(7) 2.3822(8)
Ru–S2 — — — 2.3847(7) 2.3847(7)
a Values are taken from a study by Van Rixel et al.33
Table 2 Selected angles (°) and torsion angles (°) for [1]Cl, [2a]Cl, [2b]Cl, [3](PF6)2, and [4](PF6)2. See Fig. 1 for atom numbering
Angle [1]Cla [2a]Cl [2b]Cl [3](PF6)2 [4](PF6)2
N1–Ru–N3 91.77(8) 89.89(14) 91.63(14) 90.13(9) 91.56(11)
N1–Ru–N4 170.80(8) 165.10(15) 164.72(14) 166.35(10) 169.80(10)
N1–Ru–N6 97.90(8) 97.98(15) 96.03(14) 99.08(9) 96.68(14)
N3–Ru–N4 80.78(8) 80.63(14) 80.22(14) 80.77(10) 80.94(15)
N3–Ru–N6 164.83(8) 170.92(14) 171.25(14) 168.14(9) 169.80(10)
N4–Ru–N6 90.51(8) 92.51(14) 93.22(14) 91.38(10) 91.56(11)
N1–N3–N4–N6 12.78(9) 12.5(2) 13.3(2) 13.7(1) 9.9(1)
α–βb 45.38 42.9(2) 47.0(2) 44.50(9) 30.43(15)
a Values are taken from a study by Van Rixel et al.33 b The dihedral angle α–β is formed by the planes between the terminal pyridyls (N1–C1–C2–
C3–C4–C5 and N6–C16–C17–C18–C19–C20) or quinolyls (N1–C1–C2–C3–C4–C5–C6–C7–C8–C9 and N6–C20–C21–C22–C23–C24–C25–C26–C27–
C28).
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biqbpy to ruthenium enables photosubstitution of the axial
trans ligands.
Gel electrophoresis with ODN1
ODNs have proven to be valuable model targets for anti-cancer
compounds because they can be specifically designed, and
easily studied by, for instance, mass spectrometry.42,43 As [1]Cl
is phototoxic, cytotoxic, and enters the nucleus, we aimed to
study our small library of tetrapyridyl ruthenium complexes in
their reactions with a standard ODN. Thus, the ODN
s(5′CTACGGTTTCAC3′) – hereafter denoted as ODN1 – was
reacted with [1]Cl, [2]Cl, [3](PF6)2 and [4](PF6)2 to start building
a structure–activity relationship. Like in previous studies
ODN1 contained a GG-box, an important binding motif for
cisplatin.43
First, the outcomes of the dark and photochemical reac-
tions were analyzed using gel electrophoresis to study the
influence of light on the interaction of the Ru complexes with
ODN1. The binding of a ruthenium complex to ODN1 signifi-
cantly adds to the molecular weight of the oligonucleotide,
and can add up to two positive charges per ruthenium
complex to an otherwise negatively charged oligonucleotide.
Both factors contribute to retardation during the migration of
ODN1 on the gel. In these experiments, 3 equivalents of [1]Cl,
[2]Cl, [3](PF6)2, or [4](PF6)2 were added to ODN1, light-acti-
vated, and incubated for 6 hours with 1 eq. of the ODN1
([ODN] = 0.25 mM and [Ru] = 0.75 mM]). The mixtures were
then pipetted on a gel, the gel was run, and the adducts were
visualized using toluidine blue (Fig. 3).44 Without light-acti-
vation, all complexes (Fig. 3, lanes 1, 3, 5, and 7) showed iden-
tical band migration as the untreated ODN1 control (lane 9),
indicating that under such conditions no ruthenium–ODN1
adducts formed in the dark, irrespective of the structure of the
complex. When the compounds were light-activated in the
presence of ODN1, all free ODN1 bands decreased in intensity,
and two extra bands appeared above the original ODN1 band.
This strongly indicates that each light-activated ruthenium
complex forms two distinct adducts with ODN1.
A second gel electrophoresis measurement was performed,
including 19-, 23, 24, and 31-mer oligonucleotides, and an
untreated ODN1 control sample that was irradiated (Fig. S10†).
The first ruthenium–ODN1 adduct band ended up between
the bands of the 24-mer and 31-mer control ODNs. The second
ruthenium–ODN1 adduct band ended up between the 19-mer
control and the untreated ODN1 irradiated control. As the
coordination of one of the ruthenium complexes to ODN1
would increase the molecular weight equivalent of 1–2 base
pairs, the band of such an adduct would be at the level of a 13-
or 14-mer in the case of a monoruthenium-adduct, and at the
level of a 15- or 16-mer for a bisruthenium-adduct. As
migration of the adduct bands did not correspond to these
levels, the (di)cationic charge of the ruthenium must have an
Fig. 3 Gel electrophoresis of mixtures of ODN1 (5’CTACGGTTTCAC3’)
and [2]Cl, [1]Cl, [4](PF6)2, or [3](PF6)2, on polyacrylamide gel. Lanes 1, 3,
5, and 7 correspond to the dark reaction between ODN1 and [2]Cl, [1]Cl,
[4](PF6)2, or [3](PF6)2 respectively. Lanes 2, 4, 6, and 8 have the same
composition but were irradiated. Lanes 9 and 10 correspond to ODN1
and 19–25 mer controls, respectively (in the dark). Conditions: T =
25 °C, [Ru] = 0.75 mM, [ODN] = 0.25 mM, and staining agent: toluidine
blue. Conditions: irradiation λexc = 445 nm, Δλ1/2 = 22 nm, photon flux Φ
= 2.2 × 10−7 mol s−1, tirr = 10 min, and tinc = 6 h.
Fig. 2 Evolution of the electronic absorption spectra of a solution of [2]
Cl (A) in demineralized water (5 v/v% CD3OD) of [3](PF6)2 (B) in deminer-
alized water (5 v/v% acetone-d6) upon blue light irradiation (λirr =
445 nm (Δλ1/2 = 22 nm), photon flux Φ = 1.81 × 10−7 mol s−1, tirr =
15 min). Time: 0 min (red curve) to 15 min (black curve). Conditions [Ru]0
= 0.05 mM and the irradiated volume was 3.0 mL at 298 K. Inset: a plot
of the absorbance at 350 nm (A) or 480 nm (B) as a function of
irradiation time.
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extra lagging effect on the adduct band in gel migration.
Lastly, the irradiated ODN1 control band runs at the same
level as the dark ODN1 control band, indicating that
irradiation did not have any effect on the ODN1 itself. Overall,
whereas no reaction occurred in the dark, light-activation of all
four ruthenium complexes induced strong interactions with
ODN1. However, it was impossible at this stage to characterize
these adducts.
High-resolution mass spectrometry
In order to identify these ruthenium–ODN1 adducts similar
experiments were conducted but the samples were investigated
using high-resolution mass spectrometry. For the dark reac-
tion, ODN1 was incubated in LC-MS grade water at 25 °C for
6 hours – while shielded from light – in the presence of 3
equivalents of one of the four ruthenium complexes. Then,
mass spectra in negative mode were recorded, and deconvo-
luted for clarity.45–47 Incubation of ODN1 with [1]Cl or [2]Cl
without light-activation resulted in major signals at m = 3595.7
or 3617.6 corresponding to free ODN or ODN + Na+ (calc. m =
3595.7 or 3617.6), respectively. Minor signals at m = 4213.6
corresponding to [ODN1 + Ru(biqbpy)(dmso) − 2H] (calc. m =
4212.7, see Fig. 4A and S13A†) and minor signals at m = 4113.1
corresponding to [ODN1 + Ru(bapbpy)(dmso) − 2H] (calc. m =
4112.7, see Fig. S14A†), respectively, indicated that limited
adduct formation in the dark was possible, but that the dmso
remained bound to ruthenium. When comparing [1]Cl and [2]
Cl the ratio between the adduct signals and that of the free
ODN1 was found to be lower for [1]Cl than for [2]Cl, indicating
that under such conditions [2]Cl was more susceptible to
adduct formation with ODN1 than [1]Cl. When ODN1 was
incubated with [3](PF6)2 or [4](PF6)2 the major peaks were
found at m = 3595.7 corresponding to the free ODN1 (calc. m =
3594.6, Fig. S15A and S16A,† respectively). Whereas incubation
with [3](PF6)2 resulted in virtually no ruthenium adduct
signals, with [4](PF6)2 minor signals at m = 4034.7 corres-
ponding to ruthenium adducts [ODN1 + Ru(bapbpy) − 2H]
(calc. m = 4034.7) were found. On the one hand, no Hmte
ligand stayed coordinated to the ruthenium center in such
adducts; on the other hand, these signals were of lower inten-
sity compared to that of the ruthenium adducts measured
with [2]Cl (Fig. S14A†). Overall, for both the bapbpy and
biqbpy complexes coordination of two trans thioethers inhib-
ited the formation of ODN1–ruthenium adducts, compared to
the coordination of dmso and a trans chloride ligand that is
hydrolyzed thermally in water.
Adduct-formation was also measured by ESI-MS after
mixing ODN1 and the ruthenium complex, shining visible
light (λirr = 445 nm, 10 min), followed by 6 h incubation.
With [1]Cl the signals for free ODN1 were still dominant but a
new set of peaks observed at m = 4136.3 corresponded to the
adduct [ODN1 + Ru(biqbpy) − 2H] (calc. m = 4136.7, see
Fig. 4B and Fig. S13B†). This peak was different from the peak
observed in the dark, since the dmso ligand had been
removed. With [2]Cl the strongest signals were observed at m =
4035.6 and corresponded to a similar adduct [ODN1 + Ru
(bapbpy) − 2H] (calc. m = 4034.7), while a minor set of peaks
for m = 4475.0 corresponded to the dinuclear adduct [ODN1 +
(Ru(bapbpy))2 − 4H] (calc. m = 4474.7, Fig. 4C and Fig. S14B†).
It is noteworthy that the signals at m = 3617.0 corresponding
to [ODN1 + Na] (calc. m = 3617.6) remained, but they were sig-
nificantly less intense compared to those of the dark control.
These results confirmed, on the one hand, that when bound to
ruthenium the dmso ligand has an inhibiting effect on the
adduct formation with ODN1; on the other hand, the dmso
ligand is cleaved off by light irradiation.
With [3](PF6)2 upon light irradiation new signals were
observed at m = 4135.3 corresponding to the adduct [ODN1 +
Ru(biqbpy) − 2H] (calc. m = 4134.7, see Fig. S15B†). However,
the signals at m = 3617.4 corresponding to [ODN1 + Na] were
still dominant. This behavior was similar to that found for [1]
Cl in the presence of light, which confirmed the observations
using gel electrophoresis that [1]Cl and [3](PF6)2 are, after light
irradiation, similar. With [4](PF6)2 like with [2]Cl dominant
signals were observed, after light activation, at m = 4034.8,
which corresponded to the adduct [ODN1 + Ru(bapbpy) − 2H]
(calc. m = 4034.7, see Fig. S16†). Here as well, both thioether
ligands had been photosubstituted. This result confirmed that
[4](PF6)2 and [2]Cl interact in a similar fashion with ODN1
after light irradiation, and that the bapbpy-based complexes
interact better with ODN1 compared to their biqbpy-based
analogues.
Overall, one should note that the ESI-MS method used in
these studies was not calibrated for quantitative measure-
ments. However, considering that all investigated reaction mix-
tures have a limited degree of molecular variation, a qualitative
conclusion can be drawn based on these data. Three well-
defined trends can be delineated. First, the light-activation of
the complex strongly enhances the adduct formation between
trans tetrapyridyl ruthenium complexes and ODN1, which
depends on whether none, one, or two axial ligands are co-
ordinated. Second, the nature of the tetrapyridyl ligand,
bapbpy vs. biqbpy, influences significantly the degree of
Fig. 4 Representative scheme of the deconvoluted mass spectrometry
data of ODN1 mixed with [1]Cl incubated (A) without light-activation, (B)
with light-actviation, (C) and [2]Cl with light activation. The full dataset
and interpretation can be found in the ESI.† Conditions: [ODN] =
0.03 mM, [Ru] = 0.09 mM, tirr = 10 min, tinc = 6 h, T = 298 K, λirr =
445 nm (Δλ1/2 = 22 nm), and the photon flux Φ = 2.17 × 10−7 mol s−1.
Each helix represents a DNA single strand.
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adduct formation after light activation: the bapbpy complexes
are more prone to interact with ODN1 than the biqbpy com-
plexes. Third, light activation of [2]Cl and [4](PF6)2 leads to the
formation of adducts with ODN1 that can have either one or
two bound ruthenium complexes.
Discussion & conclusion
In this work we have demonstrated that light can control the
coordination interaction between trans ruthenium complexes
with the bapbpy or biqbpy ligand and the oligonucleotide
ODN1. No traces of adducts containing one ruthenium center
and two oligonucleotides were found, indicating that under
such conditions no inter-strand crosslinking occurs. The
almost complete absence of adduct formation in the dark
demonstrates that a single dmso ligand or two trans thioethers
strongly inhibit the interaction of the metal complex with
nucleotides. Meanwhile, by combining the gel electrophoresis
and mass spectrometry results, we observed that the adducts
formed upon light activation consist of one strand bound to
one or two ruthenium complexes.
trans Ruthenium complexes cannot mimic the cisplatin
binding mode, suggesting that a different mechanism of
binding takes place producing a different type of DNA distor-
tion. While the ESI-MS data in our study suggest that after
light-activation the trans complexes have two coordination
sites available for nucleotide binding, it is hard to imagine
both being employed by coordination to adjacent DNA bases
like cisplatin. Transplatin, on the other hand, is known to
form crosslinks between different strands. We found no indi-
cation here suggesting that the trans ruthenium complexes
[1]+–[4]2+ would form adducts with two or more oligonucleo-
tides. Other interactions responsible for the binding of
metallodrugs to DNA involve hydrogen bonding with especially
the phoshphate backbone,3,48,49 or pi–pi stacking interactions
with the base pairs.50–52 However, these interactions dramati-
cally depend on the supramolecular assembly of nucleic acids
(double-strands vs. single-strands, G-quadruplexes vs. 3-way
junctions, etc.), and short single-stranded oligonucleotides
such as ODN1 cannot model such interactions. All four com-
pounds in this study are similar in terms of hydrogen-bonding
properties as they all have two non-coordinated NH bridges,
and [1]+ and [2]+ on the one hand and [3]2+ and [4]2+ on the
other hand share very similar coordination properties.
However, the complexes based on biqbpy have a stronger aro-
matic and lipophilic character compared to those based on
bapbpy, and [2]+ and [4]2+ indeed were found to bind slightly
less to ODN1 compared to their bapbpy analogues [1]+ and
[3]2+ (all other conditions being identical). Overall, non-coordi-
nating interactions may play a role in the interaction of
biqbpy- and bapbpy-based trans ruthenium complexes with
DNA, but better DNA models, e.g. double-strands, would be
necessary for such studies, as well as more quantitative analyti-
cal techniques.53 Still, oligonucleotides appear as an excellent
tool to characterize the coordination properties of (light-acti-
vated) metal-based drugs to nucleic acids, with minimal inter-
ference from secondary interactions such as hydrogen
bonding and pi–pi stacking.
Experimental part
Materials and methods
All 1H NMR spectra were recorded on a Bruker DPX-300,
DMX-400, or AV-500 spectrometer. Chemical shifts are indi-
cated in ppm relative to tetramethylsilane. Mass spectra were
recorded by using a Thermoquest Finnagen AQA Spectrometer
and an MSQ Plus Spectrometer positive ionization mode. For a
schematic representation of [Ru(bapbpy)L2] and [Ru(biqbpy)
L2] with atom numbering used in NMR attribution, see
Fig. S1.† UV-vis experiments were performed on a Cary 50




(biqbpy), and [Ru(dmso)4Cl2] were synthesized according to lit-
erature procedures.33,40,41,54 [2-(Methylthio)ethanol (Hmte)
and ODN1 (bought HPLC-purified) were purchased from
Sigma-Aldrich.
Synthesis and crystallography
Synthesis of [Ru(bapbpy)(dmso)Cl]Cl ([2]Cl). In a 2-necked
round-bottom flask [Ru(dmso)4Cl2] (200 mg, 0.413 mmol) and
bapbpy (144 mg, 0.413 mmol) were added in degassed ethanol
(30 mL). The solution was stirred overnight at 80 °C, upon
which a dark red suspension was formed. After filtration and
drying a red powder was obtained. Yield: 121 mg (50%).
1H NMR (300 MHz, 300 K, D2O): δ = 8.54 (dd, 2H J = 6.1,
1.1 Hz, Hpy-6), 8.24 (dd, 2H, J = 7.8, 0.9 Hz, H5), 8.15 (t, 2H, J =
8.1 Hz, H4), 8.05 (m, 2H, Hpy-5), 7.51 (dd, 2H, J = 8.3, 0.8 Hz,
H3), 7.45 (dd, 2H, J = 8.4, 0.8 Hz, Hpy-3), 7.28–7.18 (m, 2H,
Hpy-4), 2.43 (s, 6H, Hα). 13C NMR (100 MHz, 300 K, D2O): δ =
152.69 (Cpy-3), 140.16 (Cpy-5), 139.85 (C4), 119.46 (Cpy-4), 118.33
(C5), 116.17 (Cpy-6), 115.79 (C3), 44.44 (Cα). High resolution ES
MS m/z (calc.): 555.0304 (555.0308 for [M − H]+), 519.053
(519.054 for [M − Cl − H]+). Elem. anal. calcd for
C22H22Cl2N6ORuS: C, 44.75; H, 3.76; N, 14.23. Found: C, 44.71;
H, 3.76; N, 14.17.
Single crystals of [2]Cl were obtained by crystallization via
liquid–vapor diffusion using MeOH as the solvent and EtOAc
as the counter-solvent. In short, 1.0 mg of [2]Cl was dissolved
in 1 mL of MeOH and placed in a small GC vial. This vial was
placed in a larger vial containing 2.8 mL of EtOAc. The large
vial was closed and vapor diffusion occurred within a few days
to afford X-ray quality crystals.
Crystal data for [2]Cl. All reflection intensities were
measured at 110(2) K using a KM4/Xcalibur (detector:
Sapphire3) with enhanced graphite-monochromated Mo Kα
radiation (λ = 0.71073 Å) under the program CrysAlisPro
(Version 1.171.35.11 Oxford Diffraction Ltd, 2011). The
program CrysAlisPro (Version 1.171.35.11, Oxford Diffraction
Paper Dalton Transactions


































































































Ltd, 2011) was used to refine the cell dimensions. Data
reduction was done using the program CrysAlisPro (Version
1.171.35.11, Oxford Diffraction Ltd, 2011). The structure was
solved with the program SHELXS-2014/7 and was refined on
F2 with SHELXL-2014/7.55 Analytical numeric absorption cor-
rections based on a multifaceted crystal model were applied
using CrysAlisPro (Version 1.171.35.11, Oxford Diffraction Ltd,
2011). The temperature of the data collection was controlled
using the system Cryojet (manufactured by Oxford
Instruments). The H atoms (except when specified) were
placed at calculated positions using the instructions AFIX
43 or AFIX 137 with isotropic displacement parameters having
values 1.2 or 1.5 times Ueq of the attached C atoms. The H
atoms attached to N2n and N5n (n = A, B) were located from
difference Fourier maps; their atomic coordinates were refined
freely using some restraints (DFIX instructions).
The structure is ordered. The crystal was found to be
twinned non-merohedrally, and the twin relationship is a
twofold axis found along the direct-space vector 0.0044 0.0086
1.0000. The batch scale factor of the minor component refines
to 0.3188(11). The final structure refinement was performed
using the HKL5 instruction (true hkl files including reflection
sets for the twinned component 1 and the associated over-
lapped reflections from component 2).
Crystal data: Formula: C22H22Cl2N6O1Ru1S1. Fw = 590.48, a
small orange block, 0.22 × 0.17 × 0.14 mm3, triclinic, P1̄
(no. 2), a = 12.6164(2), b = 13.6053(3), c = 14.3404(3) Å, α =
100.1729(17), β = 92.9120(16), γ = 106.0391(17)°, V = 2315.57(8)
Å3, Z = 4, Dx = 1.694 g cm
−3, μ = 1.027 mm−1, and Tmin–Tmax:
0.831–0.900. 36 503 reflections were measured up to a resolu-
tion of (sin θ/λ)max = 0.59 Å
−1. 9478 reflections were unique
(Rint = 0.031, including the overlapped reflections from the
twin component 2), of which 7962 were observed [I > 2σ(I)].
616 parameters were refined using 4 restraints. R1/wR2 [I >
2σ(I)]: 0.0410/0.1012. R1/wR2 [all refl.]: 0.0536/0.1091. S = 1.096.
The residual electron density was found between −0.75 and
0.87 e Å−3. Deposited as CCDC 1535298.†
Synthesis of [Ru(biqbpy)(Hmte)2](PF6)2 ([3](PF6)2). In a
2-necked round-bottom flask [1]Cl (19 mg, 0.028 mmol) and
Hmte (0.24 mL, 2.7 mmol) were added in degassed deminera-
lized water (10 mL). The reaction mixture was stirred overnight
at 80 °C, resulting in a red solution. After the full conversion
was checked by TLC (eluent: acetone/water/aqueous KPF6
(sat.), 5 : 2 : 2), the reaction was cooled down to room tempera-
ture and KPF6 (0.4 g, 2.2 mmol) was added. Then, the aqueous
layer was extracted with dichloromethane (3 × 15 mL), and the
organic layer was evaporated in vacuo. The compound was pur-
ified using size-exclusion chromatography (Sephadex LH-20,
acetone). After evaporation, the product was reprecipitated
from acetone (0.5 mL) by the addition of diethyl ether (10 mL).
Yield: 19 mg (68%). 1H NMR (400 MHz, 300 K, acetone-d6): δ =
10.42 (s, 2H, NH), 8.87 (d, 2H, J = 8.8 Hz, Hqi-4), 8.68 (d, 2H, J =
7.6 Hz, Hqi-7), 8.64 (d, 2H, J = 6.8 Hz, Hqi-9), 8.40 (t, 2H, J = 8.4
Hz, Hqi-6), 8.16 (d, 4H, J = 7.6 Hz, H3 and H5), 8.02 (t, 2H, J =
7.2 Hz, Hqi-5), 7.94 (t, 2H, J = 8.4 Hz, Hqi-10), 3.39–3.32 (m, 4H,
Hβ), 2.10–2.00 (m, 4H, Hγ), 2.10–2.00 (m, 4H, Hγ), 1.53 (s, 6H,
Hα). High resolution ES MS m/z (calc.): 725.1301 (725.1309,
[M − H]+). 13C NMR (125 MHz, 300 K, acetone-d6): δ = 156.70
(C2), 152.45 (C6), 151.62 (Cqi-2), 146.11 (Cqi-9), 139.01 (Cqi-6),
137.23 (Cqi-8), 133.42 (C*), 130.09 (Cqi-5), 128.77 (C5), 123.75
(C4), 120.90 (Cqi-3), 120.84 (Cqi-7), 120.35 (Cqi-10), 118.26 (C3),
59.28 (Cβ), 38.78 (Cγ), 16.85 (Cα). Elem. anal. calcd for
C34H36F12N6O2P2RuS2 + 12acetone: C, 40.81; H, 3.76; N, 8.04.
Found: C, 40.53; H, 4.11; N, 8.37.
Single crystals of [3](PF6)2 were obtained by crystallization
via liquid–vapor diffusion using acetone as the solvent and di-
ethylether as the counter-solvent. In short, 1.0 mg of [3](PF6)2
was dissolved in 0.4 mL of acetone and placed in a small GC
vial. This vial was placed in a larger vial containing 2.8 mL of
diethyl ether. The large vial was closed and vapor diffusion
occurred within a few days to afford X-ray quality crystals.
Crystal data for [3](PF6)2. All reflection intensities were
measured at 110(2) K using a SuperNova diffractometer
(equipped with an Atlas detector) with Cu Kα radiation (λ =
1.54178 Å) under the program CrysAlisPro (Version 1.171.37.35
Agilent Technologies, 2014). The same program was used to
refine the cell dimensions and for data reduction. The struc-
ture was solved with the program SHELXS-2014/7 and was
refined on F2 with SHELXL-2014/7.55 Analytical numeric
absorption correction based on a multifaceted crystal model
was applied using CrysAlisPro. The temperature of the data
collection was controlled using the system Cryojet (manufac-
tured by Oxford Instruments). The H atoms were placed at cal-
culated positions (unless otherwise specified) using the
instructions AFIX 23, AFIX 43, AFIX 137 or AFIX 147 (for the
disordered O–H group) with isotropic displacement para-
meters having values of 1.2 or 1.5Ueq of the attached C or O
atoms. The H atoms attached to N2, N5 and O1 were found
from difference Fourier maps, and their coordinates were
refined freely using the DFIX restraints.
The structure is partly disordered. One of the two counter-
ions and O2/O2′ (OH group) are disordered over two orien-
tations. The occupancy factors of the major components of the
disorder refine to 0.624(13) and 0.77(5), respectively. The
crystal that was mounted on the diffractometer was non-mero-
hedrally twinned, and the twin relationship corresponds to a
twofold axis along the 0.0009a* + 0.9998b* + 0.0201c* vector.
The BASF scale factor refines to 0.2115(9).
Formula: C34H36F12N6O2P2Ru1S2. Fw = 1015.82, a red block,
0.21 × 0.19 × 0.14 mm3, monoclinic, P21/n (no. 14), a = 9.54745
(18), b = 21.8432(4), c = 18.4565(3) Å, β = 98.2773(17)°, V =
3808.95(12) Å3, Z = 4, μ = 6.08 mm−1, and Tmin–Tmax:
0.401–0.563. 27 773 reflections were measured up to a resolu-
tion of (sin θ/λ)max = 0.616 Å
−1. 10 943 reflections were unique
(Rint = 0.022), of which 9630 were observed [I > 2σ(I)]. 620 para-
meters were refined using 256 restraints. R1/wR2 [I > 2σ(I)]:
0.029/0.0943. R1/wR2 [all refl.]: 0.0333/0.0963. S = 0.99. The
residual electron density was found between −0.66 and 0.64 e
Å−3. Deposited as CCDC 1535299.†
Synthesis of [Ru(bapbpy)(Hmte)2](PF6)2 ([4](PF6)2). In a
2-necked round-bottom flask [2]Cl (50 mg, 0.085 mmol) and
Hmte (1.47 mL, 16 mmol) were added in degassed deminera-
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lized water (15 mL). The reaction mixture was stirred overnight
at 80 °C, resulting in a red solution. After full conversion was
ensured by TLC (eluent: acetone/water/aqueous KPF6 (sat.),
5 : 2 : 2), the reaction mixture was cooled down to room temp-
erature and KPF6 (0.5 g, 2.7 mmol) was added. Then, the
aqueous layer was extracted with ethyl acetate (3 × 15 mL), and
the organic layer was evaporated in vacuo. The compound was
purified using size-exclusion chromatography (Sephadex
LH-20, acetone). After evaporation, the product was precipi-
tated from acetone (0.5 mL) by the addition of diethyl ether
(10 mL). Yield: 45 mg (58%). 1H NMR (400 MHz, 300 K,
acetone-d6): δ = 10.56 (s, 2H, N–H), 8.80 (d, 2H, J = 6.0 Hz
py-6), 8.51 (d, 2H, J = 7.6 Hz, H5), 8.27 (d, 2H, J = 8.4 Hz, H4),
8.07 (dd, 2H, J = 8.8 Hz, py-4), 7.62 (d, 2H, J = 8.4 Hz, H5), 7.50
(d, 2H, J = 8.4 Hz, py-3), 7.36 (dd, 2H, J = 7.2 Hz, py-5), 3.42
(t, 4H, J = 5.6 Hz, Hγ), 2.01 (t, 4H, J = 5.6 Hz, Hβ), 1.56 (s, 6H,
Hα). 13C NMR (100 MHz, 300 K, acetone-d6): δ = 162.1 (C2),
154.3 (Cpy-6), 139.9 (Cpy-4), 139.2 (C4), 133.9 (C6), 130.5 (Cpy-2),
120.3 (Cpy-5), 119.2 (C5), 117.7 (Cpy-3), 116.6 (Cpy-3), 116.1(C3),
59.5 (Cγ), 38.9 (Cβ), 17.0 (Cα). High resolution ES MS m/z
(calc.): 574.0961 (574.0963, [M − H − Hmte + ACN]+). Elem.
anal. calcd for C26H32F12N6O2P2RuS2 + 12acetone +
1
2H2O:
C, 34.63; H, 3.80; N, 8.81. Found: C, 34.44; H, 4.33; N, 9.01.
Single crystals of [4](PF6)2 were obtained by crystallization
through liquid–vapor diffusion using acetone as the solvent
and diethyl ether as the counter-solvent. In short, 1.0 mg of [4]
(PF6)2 was dissolved in 0.4 mL of acetone and placed in a
small vial. This vial was placed in a larger vial containing
2.8 mL of diethyl ether. The large vial was closed and vapor
diffusion occurred within a few days to afford X-ray quality
crystals.
Crystal data for [4](PF6)2. All reflection intensities were
measured at 110(2) K using a SuperNova diffractometer
(equipped with an Atlas detector) with Cu Kα radiation (λ =
1.54178 Å) under the program CrysAlisPro (Version 1.171.36.32
Agilent Technologies, 2013). The same program was used to
refine the cell dimensions and for data reduction. The struc-
ture was solved with the program SHELXS-2014/7 and was
refined on F2 with SHELXL-2014/7.55 Analytical numeric
absorption correction based on a multifaceted crystal model
was applied using CrysAlisPro. The temperature of the data
collection was controlled using the system Cryojet (manufac-
tured by Oxford Instruments). The H atoms were placed at cal-
culated positions (unless otherwise specified) using the
instructions AFIX 23, AFIX 43 or AFIX 137 with isotropic dis-
placement parameters having values of 1.2 or 1.5Ueq of the
attached C atoms. The H atoms attached to N2 and O1 were
found from difference Fourier maps, and their coordinates
were refined freely using the DFIX instruction.
The structure is ordered. The ruthenium complex is found
at sites of twofold axial symmetry, and only one half of the
molecule is found to be crystallographically independent.
Formula: C26H32F12N6O2P2Ru1S2. Fw = 915.70, orange-red
needles, 0.25 × 0.05 × 0.02 mm3, monoclinic, I2/a, a = 18.9321
(3), b = 11.23471(18), c = 15.6066(2) Å, β = 96.7047(15)°, V =
3296.77(9) Å3, Z = 4, μ = 6.94 mm−1, and Tmin–Tmax:
0.391–0.881. 10 972 reflections were measured up to a resolu-
tion of (sin θ/λ)max = 0.616 Å
−1. 3243 reflections were unique
(Rint = 0.024), of which 3045 were observed [I > 2σ(I)]. 239 para-
meters were refined using 2 restraints. R1/wR2 [I > 2σ(I)]:
0.0378/0.1016. R1/wR2 [all refl.]: 0.0399/0.1034. S = 1.06. The
residual electron density was found between −0.74 and 2.11
e Å−3. Deposited as CCDC 1535297.†
Additional notes:
(i) The residual electron density peak of 2.11 e− Å−3 found
at 0.75 Å from Ru1 is chemically meaningless. All remaining
residual electron density peaks are lower than 1 e− Å−3.
(ii) The occupancy factor of Ru1 was refined freely (its value
was 1.034(3) × 0.5 = 0.517(2)) before being constrained to 0.5
in the final refinement.
UV-vis spectroscopy absorbance studies
Photoreactivity and stability studies were monitored using a
UV-vis spectrometer equipped with the temperature set at
298 K and a magnetic stirrer. The measurements were per-
formed in a quartz cuvette, containing 3 mL of solution
(0.010–0.050 mM). The stirred sample was irradiated perpendi-
cularl to the axis of the spectrometer with a blue LED (λ =
445 nm, Δλ1/2 = 22 nm, photon flux Φ = 2.1 × 10−8 mol s−1, tirr
= 10 minutes) fitted to the top of the cuvette, and an absorp-
tion spectrum was obtained at regular time intervals and ana-
lyzed using Microsoft Excel. Mass spectrometry was performed
at the beginning and at the end of the irradiation to confirm
the nature of the reagent and products.
Gel studies
HPLC purified ODN1 was ordered from Sigma-Aldrich and
received as a solid (fixed amount), and LC-MS water was added
in such amounts that a 1 mM solution was obtained. [1]Cl and
[2]Cl were dissolved in methanol and [3](PF6)2 and [4](PF6)2
were dissolved in acetone to obtain 1 mM solutions. Then,
5 µL of ODN solution, 15 µL of Ru solution, and 5 µL of MilliQ
water were transferred to a 1 mL quartz cuvette, and irradiated
for 10 minutes with blue LED (λirr = 445 nm, Δλ1/2 = 22 nm,
photon flux Φ = 2.2 × 10−7 mol s−1, irradiation time
10 minutes). Following irradiation, the sample was transferred
to a 1.5 mL Eppendorf microtube and incubated in the dark
for 6 hours at 298 K. Then, 1–2 μl of the mixture (containing
400 pmol of ODN1 per lane) was added to 3 μl formamide/dye
solution (formamide 0.01% (w/v), bromophenol blue 0.01%
(w/v), xylenecyanol 0.01% (w/v)) and loaded (without heating)
on a 20% polyacrylamide gel containing 8 M urea in 1× Tris/
borate/EDTA buffer. After electrophoresis (22 mA per gel) the
gel was stained for 5 min in 0.01% w/v Toluidine Blue O ((7-
amino-8-methyl-phenothiazin-3-ylidene)-dimethyl-ammonium)
in water on a rotary shaker. The background staining was
removed by washing the gel multiple times with tap water. The
procedure was adapted from Popa and Bosch.44
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HPLC purified ODN1 (s(5′CTACGGTTTCAC3′) or
C116H149N40O72P11) was ordered from Sigma-Aldrich and
received as a solid (fixed amount). LC-MS water was added in
such amounts that a 1 mM solution was obtained. [1]Cl and
[2]Cl were dissolved in methanol and [3](PF6)2 and [4](PF6)2
were dissolved in acetone to obtain 1 mM solutions. Then,
15 µL of ODN1 aqueous solution, 45 µL of Ru solution, and
450 µL of LC-MS grade water were transferred to a 1 mL quartz
cuvette, and irradiated for 10 minutes with a blue LED (λirr =
445 nm, Δλ1/2 = 22 nm, photon flux Φ = 2.2 × 10−7 mol s−1,
irradiation time 10 minutes). Following irradiation, the sample
was transferred to a 1.5 mL Eppendorf microtube and incu-
bated in the dark for 6 hours at 298 K. For every sample a
control sample shielded from light in a parallel experiment
was performed. Then, the solutions were directly injected
(flow rate = 5 μl min−1, 1 : 1 water/methanol) in an Orbitrap
high-resolution mass spectrometer (Thermo, San Jose, CA,
USA), equipped with a conventional ESI source. The mass
spectra have been recorded in the range of 300–2000 m/z
values. The following standardized working conditions were
applied: spray voltage 2.7 kV, tube lens voltage −113 V, capil-
lary voltage −20 V and capillary temperature 280 °C. Sheath
and auxiliary gases were set at 23 a.u. and 4 a.u., respectively.
The m/z spectra were deconvoluted using ProMass for Xcalibur
(ThermoQuest, Finnigan). The chemical structure of ODN1 is
shown in Scheme S12.†
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